Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1998-03-24
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514589, A61K 31445, A61K 31175
Patent
active
057313253
ABSTRACT:
A method for treatment of malignant melanoma by administering an effective amount of thalidomide alone or in combination with other anti-melanoma drugs.
REFERENCES:
patent: 5399363 (1995-03-01), Liversidge et al.
Carter et al, Chemotherapy of Cancer, 2nd Ed John Wiley & Sons, N.Y., N.Y., 1981, pp. 101 and 209.
Andrulis, Jr. Peter J.
Drulak Murray W.
Andrulis Pharmaceuticals Corp.
Angres Isaac A.
Goldberg Jerome D.
LandOfFree
Treatment of melanomas with thalidomide alone or in combination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of melanomas with thalidomide alone or in combination , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of melanomas with thalidomide alone or in combination will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2289211